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1. Introduction 
Models presented for the interaction of ligands 
with receptors in membranes are often complex. 
These models have been proposed because the kinetic 
and equilibrium data seem to demand them. Cyto- 
chrome P-4.50--substrate interactions are a case in 
point. Spectral measurements have demonstrated that 
the apparent dissociation constant for cyclohexane 
binding is a function of cytochrome P-450.concentra- 
tion [ 11. The rate of benzpyrene hydroxylation 
catalysed by cytochrome P-450 is non-linear with 
enzyme concentration except at very low enzyme 
concentrations [2]. Imipramine metabolism studies 
give KM values that are a function of protein concentra. 
tion [33. 
These, and other data on ligand-receptor inter- 
actions, are determined from analytical equations 
derived for single-phase systems, However, any mem- 
brane in suspension is a biphasic system, the phases 
being the lipid bilayer of the membrane, and the 
aqueous suspending medium, and so these expressions 
are not directly applicable. By examining the 
biphasic nature of the system, we here derive kinetic 
and equilibrium expressions for an accurate analysis of 
ligand-receptor interactions in membranes, and 
suggest suitable methods for determining true dissocia- 
tion and kinetic constants. This involves considering 
the distribution of substrate between the two phases, 
and then how this distribution affects binding and 
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kinetic expressions in terms of the experimental 
variables used and measured in such work. 
2. General formulation 
2.1. Substrate distribution 
Define S as total moles of free substrate, S, as 
the number of moles in the aqueous phase, SIlp as the 
number of moles in the lipid phase; V as the total 
volume, vaq as volume of the aqueous phase, and 
vbp as the volume of the lipid phase, and (X) is the 
concentration of X. 
All unbound substrate will partition between the 
two phases, such that, 
S=Sbp ts, (1) 
This distribution will be controlled by the partition 
coefficient, defined as, 
K - (‘Iip 
’ - (9, 
Nowas V==agt%P 
(2) 
then (s) v = (SIC, vgp + Qa, vaq 
and when the relative volume of lipid is small, 
v = Vaq 
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then @‘I = (s)ti, qip + (s>,, - 
V 
(3) 
Substituting from (2) gives, 
Thus (‘)a, = I(, ulip t 1 
v 
(44 
and (Qlip = (9 
%p + 1 
(4b) 
7 Kp 
2.2. interaction of ligand and receptors 
In a single phase system, that contains a receptor E 
EtS + ES 
the binding of the ligand is defined by 
As (E,) = (@ t (ES), where (E,) is intial receptor 
concentration, substitution gives 
(5) 
Often what is known experimentally is not (S), the 
equilibrium ligand concentration, but (So), the initial 
(or total) ligand concentration. 
and (So) = Q + (Es) + C(ps)i 
i 
where T(PS)i = concentration of ligand receptors 
other than’the one being considered, 
thus (Es) = 
CEO) {(So) - (Es) - ~(f’fj’)i} 
K, + { (so) - (Es) -mi) 
(6) 
i 
Under experimental conditions when (So) >> (ES) + 
F(PLQ this simplifies to, 
(Es) = 
(4,) (So) 
K, + (So) 
(7) 
In a membrane suspension, however, this equation 
does not hold using the value (So), even when the 
condition, 
(So) >> (Es) + C(Ps)i is met. 
i 
The ligand concentration relevant to the binding 
equation is that exposed to the receptor active site, 
not the total added to the system. For a lipid faced 
binding site it is (So)lip, the ligand concentration in 
the lipid that is relevant, and for an aqueous faced 
binding site it is (S,)ag, the ligand concentration in 
the suspending medium, as these are the concentra- 
tions equilibrating with the binding site. Further, as the 
receptor density in the membrane is constant, it is not 
possible to change its concentration without changing 
the relative lipid volume. 
i.e. vlip (Y (E,) 
V 
and defining k’ as the receptor density coefficient, 
then ufit, = k’ (E,) 
- 
V 
(8) 
Thus, substituting into eqs. (4a) and (4b), to obtain 
Q,, and (s>lin values, and then into eq. (7), the 
equilibrium concentrations of ligand-receptor com- 
plexes can be defined as, 
(4,) (So) 
(Es) = ?C (K s P k’(E 0 ) + 1) t (S 0 ) 
(94 
for an aqueous faced binding site 
and (ES) = 
(Eo) (So) 
K,(k’W,) + M$,) + (So) 
(9b) 
for a lipid faced binding site. 
Under conditions when (S,) >P (Es) + LX (PS& 
i 
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Fig.1. Variation of enzyme-substrate concentration with 
initial enzyme concentration for single phase and biphasic 
membrane systems. 
the equilibrium concentrations of ES are more complex 
functions of receptor concentration, and a simple 
analysis of the binding behaviour cannot be carried 
out. For a further treatment see Appendix I. 
2.3. The dependence of (ES) on (EO) in biphasic 
systems 
From eqs. (9a) and (9b), it can be seen that even 
for the simple model considered, (Es) does not vary 
linearly with (Eo) at constant substrate concentration. 
In fact plotting (Es) against (E,) gives a hyperbolic 
curve (fig.1). This is in sharp contrast to the linear 
relationship obtained in single phase systems. As a 
consequence of this behaviour, receptor concentration 
can only be calculated from ligand-receptor con- 
centration under strictly controlled conditions. 
At low enzyme concentrations, 
when (KPk’(Eo) + 1) ‘v 1 for an aqueous faced 
binding site 
(ES-I = 
(4,) (So) 
K, + (So) 
and when (k’(E,) + l/K,) = l/KP for a lipid faced 
binding site, 
(Es) = JEo) (So) 
KsIKp + (So> 
Alternatively when the substrate concentration is 
high, such that 
(So) >> Ks(kpk’(Eo) + 1) for an aqueous faced site, or 
(So) >> K,(k’(E,) + 1 /K,) for a lipid faced site, then 
(ES) % (E,) in both cases. 
2.4. l7re determination of true dissociation constants 
Writing eqs. (9a) and (9b) in the form, 
(4,) (So) 
(Es> = 2 am + (s S 0 ) 
where KsaPP is the apparent dissociation constant 
obtained in such a system, 
then KsaPP = K,( 1 + Kpk’(Eo)) for an aqueous 
faced binding site, 
and KsaPP = K,( 1 /KP + k’(E,)) for a lipid faced 
binding site. 
Then as (E,) + 0, KsaPP -+ KS for an aqueous faced 
site, and KsaPP + KJK, for a binding site exposed to 
the lipid bilayer. In both cases Ksapp/Ks varies 
linearly with enzyme concentration. Thus when the 
binding site is equilibrating with the aqueous com- 
partment, the real dissociation constant can be 
obtained by determing KsaPP over a range of mem- 
brane concentrations and extrapolating to zero 
membrane concentration. For a receptor with a lipid 
faced active site, a similar analysis gives K,/K,, and 
KS can be obtained only if Kp is known. 
2.5. Change of substrate and the deviation from 
single phase behaviour 
KsaPP is independent of substrate concentration for 
both environments considered. It is, however, a func- 
tion of the partition coefficient and thus will vary with 
the nature of the substrate used. The variation of 
KsaPp;IKs with K, is demonstrated in figs. 2(a) and (b). 
When the binding site faces the lipid 
KsaPP -+ K,k’Q, as K, -+ m 
i.e. for highly lipophilic compounds, 
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Fig.2. Change of substrate and the deviation from single phase behaviour. (a) Binding site in the aqueous phase. (b) Binding site 
in the lipid phase. 
and KsaPP i m as K, + 0 
i.e. for highly hydrophilic compounds. 
When the binding site faces the aqueous phase, 
i.e. for highly lipophilic compounds, 
and KsaPP -, K, as K, + 0 
i.e. for highly hydrophilic compounds. 
In this latter case, the variation of (ES) with Q 
thus approaches that in single phase systems. 
2.6. Kinetics of membrane-bound enzymes 
For any system where, 
E+SE1 - ES --t% Et Products 
‘k-l 
and where .---- = 0, and ‘in the absence of inhibi- 
tion dt 
then d(P) _ k+2 @o) (s) 
dt k-1 + k+2 --___ + 6) 
k+1 
On writing 
k-1 + k+2 
k+l 
=K, 
then the initial rate, ‘& = f$$S$- (10) 
M LO 
This equation is now of exactly the same shape as 
that used for binding. Again substitution can be made 
for (Se) to obtain the equations for the two types 
of active site possible for membrane-bound receptors. 
If it is assumed that equilibration of substrate 
between the two phases is fast compared with the rate 
of reaction, exactly the same arguments and limita- 
tions apply as in the binding discussion, and we 
obtain for the initial rate, 
d(P) k+2 (Eo) (So) 
dt(t=o) 
I 
K,(K,k V’,) + 1) + (so) 
OW 
for an active site facing the aqueous phase 
and d(P) _ k+2 cEo) @o) __...~~_._ 
dt(t=o) K,,#IK, + k’(E,)) t (So) 
(1 lb) 
for an active site facing the lipid. 
Thus, in the same way as the ligand-receptor 
concentration is not a linear function of (E,), neither 
is the initial rate of reaction. In both environments nf 
d(P) the active site, plotting ----~ against (E,) gives a 
dt,=u 
hyperbolic curve. Again this is in contrast to single 
phase systems where such a result requires a complex 
model. The limiting conditions for linearity of initial 
rate with enzyme concentration are the same, 
exchanging KM for KS. For substrate saturation in 
both cases, 
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9 = k+2 (E,) 
and when the enzyme concentration is sufficiently 
low 
d(P) k+2 @,I (so) ___- = 
Q=O) KM + 6%) 
for an aqueous faced active site, 
and d(pL = - k+2 (E,) (K, ) 
dt(,o) KdKp + (so> 
for a lipid faced active site. 
2.5. YIie determination of true Michaelis constants 
The equations for initial rates (11 a) and (11 b) are 
exactly the same shape as those for binding, eqs. (9a) 
and (9b). Consequently the relationship of KMaPp, 
determined from single phase analysis, to KM, is 
exactly the same as the relationship between KsaPP, 
and K,. KM or KM/Kp can be determined from 
KMapp in the same way as K, or Ks/Kp are determined 
from KsaPP. 
3. Discussion 
The analysis presented here supposes that two 
factors be considered when examining ligand- 
receptor interactions in membranes. These are the 
partitioning of the ligand between the aqueous phase 
and the membrane lipid, and the location of the 
receptor binding site with respect to the lipid 
environment. We know of no occasion when the 
consequences of these two factors have previously 
been considered, and suggest hat reported estimates 
of binding and catalytic constants may be seriously 
in error. There is strong experimental evidence 
supporting the analysis derived and a few examples 
follow. Most of our evidence refers to cytochrome 
P-450-ligand interactions, since this is a system 
in which receptor binding of lipophilic compounds 
has been extensively studied. However, the con- 
sequences of the theory are perfectly general, and 
need to be considered whenever receptor-ligand 
interactions are examined in membranes. 
Schuster and her associates [4], have studied 
the interaction of a substituted pleuromutilin with 
rat liver microsomes using both equilibrium dialysis 
and spectral techniques. They have obtained evidence 
that a large pool of the drug is in the membrane and 
its presence is a consequence of the membrane lipids, 
not the membrane proteins. It is suggested that this 
pool may be in equilibrium with a hydrophobic 
binding site on cytochrome P-450. Cohen and 
Mannering [S] have obtained evidence for such a 
site on cytochrome P-450 using alcohols to inhibit 
p-hydroxylation of aniline. The extent of inhibition 
increased with increasing hydrophobicity of the 
alcohol, consistent with the interaction taking place in 
a hydrophobic environment. 
Stronger evidence for both conclusions has been 
obtained by Ibbetson and Freedman [6]. Using 
fluorescence techniques they have demonstrated that 
benzypyrene binding corresponded to a general 
dissolution of the hydrocarbon in the non-polar 
matrix of the membrane. When a first-order dissocia- 
tion constant was assumed for this process a value of 
1 PM was determined. This value is no higher than 
the determined values for benzpyrene hydroxylation 
[7,8]. This anomaly that the affinity of benzpyrene 
for the membrane is at least as high as that for the 
specific binding site of the enzyme, can be best 
explained if the enzyme active site is in the lipid 
environment. Using Ibbetson and Freedman’s data 
it is possible to calculate a partition coefficient of 
approximately 4.39 X IO3 for benzpyrene partitioning 
between lipid and aqueous phases (Appendix II). 
Since the experiments were carried out at low enzyme 
concentration, assuming KM app = KM/K,, a true 
KM value of -0.23 mM is obtained for hydroxylation 
of benzpyrene. The substrate has then of the order 
of a thousand fold greater affinity for the enzyme 
than it does for the membrane lipids. 
Gillette has also provided data in support of this 
formulation, in that KM app values for imipramine 
metabolism are a function of membrane concentration 
if values are estimated in a traditional way using total 
imipramine concentration [3]. They are, however, 
independent of membrane concentration if the 
aqueous concentrations of imipramine are used. This 
is expected as the lipid concentrations will be 
directly proportional to the aqueous concentration 
if the distribution of substrate is controlled by a 
partition coefficient. 
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Although the notion of a pool of substrate dis- 
solved in the membrane has been postulated previously, 
this has generally been treated as controlled by a 
first-order binding constant, and some experimental 
evidence has been presented in favour of such an idea. 
Apart from the contradiction of postulating, on the 
one hand, a free pool of mobile substrate, and on the 
other hand, a direct lipid-substrate interaction at a 
molecular level, there is evidence against using a first 
order constant to describe the interaction and the 
evidence in favour of it is open to other interpreta- 
tions. Blyth et al. [9] have found that sex steroid 
binding to rat liver microsomes is linear with concentra- 
tion of the hormone, and that the postulated ‘loose 
binding site’ was not saturable, consistent with the 
distribution being controlled by a zero order parti- 
tion coefficient. Schuster et al. (41 also found near 
linearity of ‘binding’ of pleuromutilin to rat liver 
microsomes and iiposomes but did eventually saturate 
the postulated binding site. A likely explanation of 
their saturation is that with increasing ligand con- 
centration, the ligand itself becomes a significant 
component of the lipid phase and modifies the 
solubility properties of the membrane. This is 
supported by the fact that changes in lipid com- 
position can vastly modify the bulk properties of a 
membrane including solubility of substances in it. 
The failure to find a simple integral relationship of 
ligand to any lipid component at saturation is not 
consistent with the use of a first order constant to 
describe the interaction. A zero-order description is 
then quite consistent, with slight deviations at low 
concentrations, as concentration rather than activity 
terms are used, and ‘substrate saturation’ being a con- 
sequence of changing the physical properties of the 
bilayer, rather than saturating a binding site in it. 
It is also possible that appreciable concentrations of 
substrate in the bilayer may change the position of 
phase transition points of the membrane, and thus 
affect the activity of lipid-dependent proteins. 
A limitation on the accuracy to which real K, and 
KM values can be determined is imposed by the 
accuracy to which K, values can be estimated. 
Schuster et al. [4], have pointed out that partitioning 
is very sensitive to lipid composition, particularly 
cholesterol levels. It is therefore important to measure 
partition coefficients in the direct environment of the 
binding site, rather than use a model system (e.g. 
128 
octanol/HzO) for estimating values. A further con- 
sideration is the possibility that saturation of a lipid 
facing enzyme may not be possible. If the saturation 
level of the lipid itself is lower than that of the 
enzyme, then the limiting substrate concentration 
accessible to the binding site may be too low to 
permit saturation of the site itself. This would lead to 
errors in determination of K, and KM values. 
Of some significance, in relation to the theory 
derived are experimental techniques used for determin- 
ing thermodynamic and kinetic parameters. Many of 
the binding constants are determined from ‘bound 
versus ‘free’ plots of various sorts, e.g. Scatchard 
plots. In terms of our analysis what is normally con- 
sidered ‘free’ in such work is in fact Sa,, and the 
‘bound’ component is {Slip + ES}. If a binding site is 
directly exposed to the lipid environment then such 
values are not meaningful to the determination of 
binding constants, and the analysis of Scatchard plots 
and the like becomes extremely complex. 
The experimental determination of enzyme levels 
from kinetic analysis, particularly when induced and 
non-induced levels of enzyme are compared, is also 
open to error. The constant k’ is a measure of the 
enzyme or receptor density in the membrane and is a 
parameter that may change following induction of 
enzyme synthesis. Again the cytochrome P-450 com- 
plex has been considered in depth in this respect and 
a vast amount of literature has accumulated 
suggesting that enzyme density can be changed by 
administration of a number of drugs, steroids and 
carcinogens (for review see [lo]). It is clear from 
eqs. (11 a) and (11 b) that in biphasic systems the 
departure from linearity of rate versus enzyme con- 
centration plots is a function of the constant k’. 
Thus when attempting to estimate enzyme levels in 
induced and non-induced states, it is important to 
establish linearity for both membranes. An enzyme 
concentration at which this is true in one membrane, 
may not be a valid concentration for estimation in 
another membrane of different enzyme density. 
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Appendix I 
Factors influencing the equilibrium concentration of 
ES when (So) > > T(PS)_j + (ES) 
The concentration of protein bound substrate is 
given by, 
X(SPJ = .qspi>aq t c(sP&p 
i i 
This can be expressed in terms of total protein 
concentrations, 
X(pi),, blip, such that 
i i 
where Kai and Kli are dissociation constants for SPI’,, 
and Spi,, respectively. 
Under conditions when (So) >> (E,), 
then (S),, is a function of (So); q+; (Pa)r , . . . . . 
*w 
(Pa), ; (PI), . . . . (Pl), 
and hence (ES) will be a function of (E,), (So), vliP, 
u,q 
(Wr . . . (Pa), and (PI), . . . (PI),. 
Appendix II 
7he determination of the partition coefficient of 
benzpyrene between the aqueous suspending medium 
and the membrane lipid 
The calculations are based on data from Ibbetson 
and Freedman [6]. 
At a total benzpyrene concentration of 16 PM, 
and a membrane protein concentration of 0.32 mg/ml, 
18 I.tmol of benzpyrene are bound/g protein. Thus in 
a volume of 1 litre, 5.76 pmol of benzpyrene are 
bound and 10.24 I.tmol are free. Assuming a phospho- 
lipid : protein ratio for smooth microsomes of 0.4 
[ 1 l] , then 0.128 g phospholipid contains 5.76 pmol 
of benzpyrene. Assuming a density of 1 g/ml for a 
phospholipid bilayer [ 121, then (benzpyrene)ti, 2 
45 mM, and (benzpyrene& - 10.24 yM. Thus K, - 
4.39 x 103. 
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